Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research

News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971

Pipeline Watch: Top-Line Phase III Results With Isatuximab, Margetuximab

Sun, 02/10/2019 - 10:38pm

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...

      Related Stories 

Grey Wolf To Use £10m Series A To Illuminate Tumors For Destruction

Sun, 02/10/2019 - 8:59pm

UK's Grey Wolf Therapeutics completes £10m Series A financing for use in altering tumor cells, illuminating them for attack and...

      Related Stories 

Finance Watch: Gossamer, Alector And Harpoon Launch First Biopharma IPOs Of 2019

Fri, 02/08/2019 - 2:08pm

Public Company Edition: Grossing $276m, Gossamer would have been the third-largest biopharma IPO in the US if it had launched...

      Related Stories 

Patent Rebuff For Roche’s Valcyte In India, Again

Fri, 02/08/2019 - 7:09am

Roche’s powder formulation for Valcyte (valganciclovir) has failed to secure a patent in India, at least for now, with the...

      Related Stories 

Mehta Analysis: Time Has Come To Present Drugs As Consumer Products

Fri, 02/08/2019 - 1:24am

Trump’s proposal to remove safe harbor protection for PBMs and biopharma will accelerate challenges to the traditional biopharma models, argues...

      Related Stories 

Lilly Sees New Product Gains, But Older Drugs Still Limit Growth Potential

Wed, 02/06/2019 - 5:04pm

Lilly noted strong growth for new products, but gains seen in the fourth quarter included older products with limited potential...

      Related Stories 

Cipla Bullish For Future, Caps Speculation On Top-Level Departures

Wed, 02/06/2019 - 7:18am

After a tough Q3, Cipla indicates that things are looking up as it readies to enter fiscal 2020, with both...

      Related Stories